海特生物
(300683)
| 流通市值：26.53亿 | | | 总市值：28.50亿 |
| 流通股本：1.22亿 | | | 总股本：1.31亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 438,429,234.33 | 286,449,829.65 | 138,635,351.99 | 688,625,991.71 |
| 营业收入 | 438,429,234.33 | 286,449,829.65 | 138,635,351.99 | 688,625,991.71 |
| 二、营业总成本 | 506,037,628.53 | 329,717,737.62 | 154,418,438.44 | 691,221,652.42 |
| 营业成本 | 244,729,599.06 | 164,681,566.06 | 77,946,656.84 | 354,881,874.46 |
| 税金及附加 | 3,910,419.48 | 2,729,895.95 | 1,145,556.42 | 5,636,236.99 |
| 销售费用 | 99,323,724.23 | 67,526,165.36 | 31,395,711.58 | 126,705,109.32 |
| 管理费用 | 73,081,178.99 | 48,416,899.27 | 23,017,903.24 | 93,811,376.92 |
| 研发费用 | 90,738,631.99 | 51,132,800.47 | 24,195,180.16 | 121,434,024.72 |
| 财务费用 | -5,745,925.22 | -4,769,589.49 | -3,282,569.8 | -11,246,969.99 |
| 其中:利息费用 | 1,716,648.02 | 1,088,856.22 | 369,048.68 | 1,117,252.6 |
| 其中:利息收入 | 7,788,983.64 | 6,107,337.43 | 3,799,948.32 | 12,857,611.16 |
| 加:公允价值变动收益 | 11,651,982.37 | 6,814,345.8 | 2,330,029.95 | 12,674,188.98 |
| 加:投资收益 | 2,986,990.7 | 2,147,846.27 | 2,355.62 | 11,041,365.11 |
| 资产处置收益 | -2,179,599.91 | 39,211.31 | 39,211.31 | -93,883.44 |
| 资产减值损失(新) | 1,685,549.35 | 3,112,195.94 | 3,760,991.99 | -33,211,740.4 |
| 信用减值损失(新) | 2,161,118.71 | 2,092,858.66 | 947,221.98 | -3,794,857.17 |
| 其他收益 | 8,228,476.2 | 6,276,583.36 | 2,152,823.43 | 9,158,065.17 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -43,073,876.78 | -22,784,866.63 | -6,550,452.17 | -6,822,522.46 |
| 加:营业外收入 | 121,845.45 | 112,148.84 | 97,533.05 | 423,830.12 |
| 减:营业外支出 | 6,220,852.65 | 2,045,491.47 | 362,233.97 | 1,425,261.59 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -49,172,883.98 | -24,718,209.26 | -6,815,153.09 | -7,823,953.93 |
| 减:所得税费用 | -19,556,716.17 | -11,901,090.58 | -5,099,856.83 | 74,181.17 |
| 六、净利润 | -29,616,167.81 | -12,817,118.68 | -1,715,296.26 | -7,898,135.1 |
| 持续经营净利润 | -29,616,167.81 | -12,817,118.68 | -1,715,296.26 | -7,898,135.1 |
| 归属于母公司股东的净利润 | -26,439,471.42 | -11,127,732.26 | -1,472,018.93 | -14,029,613.72 |
| 少数股东损益 | -3,176,696.39 | -1,689,386.42 | -243,277.33 | 6,131,478.62 |
| (一)基本每股收益 | -0.21 | -0.09 | -0.02 | -0.11 |
| (二)稀释每股收益 | -0.21 | -0.09 | -0.02 | -0.11 |
| 九、综合收益总额 | -29,616,167.81 | -12,817,118.68 | -1,715,296.26 | -7,898,135.1 |
| 归属于母公司股东的综合收益总额 | -26,439,471.42 | -11,127,732.26 | -1,472,018.93 | -14,029,613.72 |
| 归属于少数股东的综合收益总额 | -3,176,696.39 | -1,689,386.42 | -243,277.33 | 6,131,478.62 |
| 公告日期 | 2023-10-25 | 2023-08-31 | 2023-04-25 | 2023-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |